O Juan
Overview
Explore the profile of O Juan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
201
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodriguez-Vida A, Valderrama B, Castellano D, Pinto A, Mellado B, Puente J, et al.
ESMO Open
. 2024 Aug;
9(9):103690.
PMID: 39214051
Background: Platinum-based chemotherapy (ChT) has been the standard first-line treatment for metastatic urothelial carcinoma (mUC). The purpose of this study was to evaluate the use of induction avelumab followed by...
2.
Remon J, Nadal E, Domine M, Ruffinelli J, Garcia Y, Pardo J, et al.
Lung Cancer
. 2020 Jul;
147:83-90.
PMID: 32682189
Background: Malignant mesothelioma is a rare but aggressive tumor arising from the pleura, typically associated with exposure to asbestos. The purpose of this investigation was to describe mesothelioma patient characteristics,...
3.
Majem M, Juan O, Insa A, Reguart N, Trigo J, Carcereny E, et al.
Clin Transl Oncol
. 2018 Nov;
21(1):3-17.
PMID: 30446985
Non-small cell lung cancer (NSCLC) accounts for up to 85% of all lung cancers. The last few years have seen the development of a new staging system, diagnostic procedures such...
4.
Remon J, Isla D, Garrido P, De Castro J, Majem M, Vinolas N, et al.
Clin Transl Oncol
. 2017 Jun;
19(12):1537-1542.
PMID: 28660482
Background: The WORLD07 project is a female specific database to assess the characteristics of women with lung cancer. Methods: WORLD07 database sets up in 2007, and prospectively stores clinical characteristics,...
5.
Isla D, Majem M, Vinolas N, Artal A, Blasco A, Felip E, et al.
Clin Transl Oncol
. 2016 Nov;
19(5):527-535.
PMID: 27885542
Lung cancer is the most common cancer globally and has the highest mortality. Although this disease is not associated with a particular gender, its incidence is rising among women, who...
6.
Juan O, Yousaf N, Popat S
Clin Oncol (R Coll Radiol)
. 2016 Oct;
29(1):e1-e4.
PMID: 27686969
No abstract available.
7.
De Castro J, Gonzalez-Larriba J, Vazquez S, Massuti B, Sanchez-Torres J, Domine M, et al.
Clin Transl Oncol
. 2016 Jul;
19(2):219-226.
PMID: 27371031
Background/aim: First-line bevacizumab-based therapies have been shown to improve clinical outcomes in patients with non-squamous non-small-cell lung cancer (NSCLC). We aimed to descriptively analyse patients with non-squamous NSCLC who received...
8.
Esteban E, Majem M, Martinez Aguillo M, Martinez Banaclocha N, Domine M, Gomez Aldaravi L, et al.
Cancer Epidemiol
. 2015 Mar;
39(3):291-7.
PMID: 25766256
Background And Objectives: The aim of the REASON study is to determine the frequency of EGFR mutation in advanced non-small cell lung cancer (aNSCLC) patients in Spain (all histologies), and...
9.
Juan O, Vidal J, Gisbert R, Munoz J, Macia S, Gomez-Codina J
Clin Transl Oncol
. 2013 Nov;
16(7):637-43.
PMID: 24217975
Purpose: To evaluate the association in the change of circulating tumor cell (CTC) levels and clinical outcomes (PFS and OS) in patients with advanced non-small cell lung cancer (NSCLC) treated...
10.
Almenar D, Mayans J, Juan O, Garcia Bueno J, Lopez J, Frau A, et al.
Eur J Cancer Care (Engl)
. 2008 Dec;
18(3):280-6.
PMID: 19076208
Daily granulocyte colony-stimulating factors [(G-CSFs); e.g. filgrastim, lenograstim] are frequently used to reduce the duration of chemotherapy-induced neutropenia (CIN) and the incidence of febrile neutropenia (FN) in cancer patients. A...